Project Grant R21EB037871
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), awarded The Regents of the University of California, operating as Lawrence Berkeley National Laboratory, a Project Grant of $430,109 beginning June 1, 2026, with completion targeted for March 31, 2030. This award supports fundamental biomedical research focused on developing deeply subwavelength near infrared imaging technology using...
- Federal Project Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded The Washington University a $598,134 Project Grant on August 5, 2025, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop sensing collimator technology for ultrasensitive Single Photon Emission Computed Tomography (SPECT) imaging of targeted radiopharmaceutical therapies. The four-year project, concluding...
- Federal Project Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $161,000 Project Grant to the University of California, Davis on May 1, 2026, under CFDA 93.286 (Discovery and Applied Research for Technological Innovations to Improve Human Health). The award funds a two-year research initiative through April 30, 2028, focused on developing an affordable dynamic total-body positron emission tomography (TB-PET) imaging system utilizing sparse...
- Federal Grant Award Summary Lawrence Berkeley National Laboratory, operating under The Regents of the University of California, received a $197,930 Project Grant award from the National Institutes of Health (NIH) Office of the Director through the Trans-NIH Research Support program (CFDA 93.310) on September 16, 2025, with a completion date of August 31, 2027. The project develops a non-invasive biodosimetry technology using Fourier Transform Infrared Attenuated Total Reflection (FTIR-ATR)...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded The Johns Hopkins University a Project Grant totaling $507,987 on April 23, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award supports research and development of scintillator-based photon counting detector (PCD) technology for X-ray computed tomography (CT) systems, with work to be performed in...
- Federal Grant Award Summary The University of California, Davis received a $1.23M Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective July 1, 2025, through March 31, 2029. The award funds development and application of PET-enabled dual-energy computed tomography (DECT) imaging technology. The project addresses a critical...
- Federal Grant Award Summary Yale University received a $1.4 million Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective July 1, 2025, with completion targeted for March 31, 2029. The award supports development and optimization of a next-generation, modular time-of-flight (TOF) positron emission tomography (PET) scanner prototype...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded University of California, Berkeley a $1.28 million Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) effective July 1, 2025, with completion targeted for May 31, 2029. This award funds research and development of digital programmable radiofrequency (RF) coils designed to advance ultra-high-field (7 Tesla)...
- Federal Project Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded $618,670 to The Washington University under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) on August 1, 2025, with completion targeted for July 31, 2028. This Project Grant supports the development of novel positron emission tomography (PET) radiotracers targeting the tandem pore domain halothane-inhibited K+ channel 1...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded a $712,375 Project Grant to the University of California, Berkeley, effective April 1, 2026 through March 31, 2031, under the Cancer Detection and Diagnosis Research Program (CFDA 93.394). The grant supports development of the ADAPT PRO system, a digitally programmable radiofrequency (RF) imaging platform designed to enable Magnetic Resonance Imaging (MRI) of multiple nuclear isotopes beyond the standard hydrogen-1...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $312,165 Project Grant to Lawrence Berkeley National Laboratory effective June 1, 2026 through April 30, 2028 under CFDA 93.286 (Discovery and Applied Research for Technological Innovations to Improve Human Health). The research project, "Exploiting Time-of-Flight in Photon Cascade Emissions for Direct Imaging of Therapeutic Radionuclides," develops a novel nuclear imaging modality called time-of-flight multi-photon emission tomography (TOF-MPET) designed to improve detection and imaging of radiopharmaceutical therapies (RPTs), particularly alpha-therapy radionuclides injected at very low activities where conventional single-photon emission computed tomography (SPECT) lacks sufficient sensitivity. The project addresses a significant clinical gap in theranostic medicine—the inability to accurately image and monitor alpha-based cancer therapies using existing imaging technologies. By leveraging subnanosecond gamma-cascade emissions and coincidence detection with time-of-flight capabilities, the research aims to dramatically improve signal-to-noise ratio and imaging sensitivity for therapeutic radionuclides including those currently used in beta and alpha therapies. The resulting technology would enable more precise targeting of radiation doses to tumor cells while sparing healthy tissue, ultimately improving patient outcomes through better-informed treatment planning and delivery in radiopharmaceutical cancer therapy applications.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $312.2k | 6/2/26 |